-
Mashup Score: 12FDA Approval of Adjuvant Sunitinib for Renal Cell Cancer - 2 day(s) ago
This Viewpoint examines the data and circumstances behind the US Food and Drug Administration approval of sunitinib as adjuvant treatment for patients with resected renal cell carcinoma who are at a high risk of relapse.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
February 16 2025-60th Anniversary of Canada’s Flag & Rethinking Cancer Drug Trials Were you flying our flag this weekend? February 15th marked the 60th anniversary of the red and white Maple Leaf and with Donald Trump’s continuing threats against our sovereignty and economy, Flag Day took on a special meaning. I talked with Historica Canada’s Anthony Wilson-Smith about the history of the flag that was first raised on Parliament Hill in 1965. And It seems obvious that new cancer drugs and the clinical trials that test them should put the needs of cancer patients first but according to a group of oncologists, in the last decade, many new treatments have had very small benefits. They have laid out the principles for improving cancer trial design in the influential online journal The Lancet Oncology. I reached Dr. Bishal Gyawali in Kingston.
Source: www.zoomerradio.caCategories: General Medicine NewsTweet
-
Mashup Score: 11FDA Approval of Adjuvant Sunitinib for Renal Cell Cancer - 3 day(s) ago
This Viewpoint examines the data and circumstances behind the US Food and Drug Administration approval of sunitinib as adjuvant treatment for patients with resected renal cell carcinoma who are at a high risk of relapse.
Source: jamanetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 1
Read full-text medical journal articles from Medscape’s Skills Lab: Interpreting Clinical Research with Bishal Gyawali.
Source: www.medscape.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Skills Lab: The Importance of the Primary Endpoint - 8 day(s) ago
Dr Bishal Gyawali discusses the importance of the primary endpoint in phase 3 clinical trials.
Source: www.medscape.comCategories: General Medicine NewsTweet
-
Mashup Score: 14When a Cancer Drug Shortens Life: Lessons From ARIEL4 - 8 day(s) ago
Dr Gyawali unpacks the ARIEL4 trial, in which a cancer drug shortened survival by 6 months. What went wrong, and what can we learn to prevent future harm?
Source: www.medscape.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
Bishal Gyawali: Explore Two New Publications This Week! / Bishal Gyawali, cancer, OncoDaily, Oncology, Pancreatic Cancer
Source: oncodaily.comCategories: General Medicine NewsTweet
-
Mashup Score: 3
Bishal Gyawali: Treatment Innovations in Pancreatic Cancer / ASCO25, Bishal Gyawali, cancer, Kevin C Soares, Kim A. Reiss, OncoDaily, Oncology, Robert J. Torphy
Source: oncodaily.comCategories: General Medicine NewsTweet
-
Mashup Score: 49Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study - 17 day(s) ago
Top Ten US Cancer Centers make screening recommendations inconsistent with those of the USPSTF recommendations, with cancer centers generally recommending more screening and omitting a nuanced discussion of benefits and risks. Given the national and international reputation of these cancer centers, their recommendations can have important population level implications, including confusion in the public.
Source: www.thelancet.comCategories: General Medicine NewsTweet
-
Mashup Score: 1Congruence of cancer screening recommendations between the USPSTF and the top ten US cancer centers: a cross sectional study - 19 day(s) ago
Top Ten US Cancer Centers make screening recommendations inconsistent with those of the USPSTF recommendations, with cancer centers generally recommending more screening and omitting a nuanced discussion of benefits and risks. Given the national and international reputation of these cancer centers, their recommendations can have important population level implications, including confusion in the public.
Source: www.thelancet.comCategories: General Medicine NewsTweet
This is a very positive step towards addressing regulatory capture. https://t.co/540NYOeIqB https://t.co/CyfFJDqMuK https://t.co/RcQTg1oyaT